Huiyu Pharmaceutical (688553.SH) announced its results for the first three quarters, with net profit of 103 million yuan, turning a year-on-year loss into profit

Zhitongcaijing · 3d ago

According to Zhitong Finance App News, Huiyu Pharmaceutical (688553.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 866 million yuan, an increase of 16.71%; net profit to mother was 103 million yuan, turning a year-on-year loss into a profit; deducted non-net profit of 134 million yuan, an increase of 68.59% over the previous year; and basic earnings per share were 0.17 yuan.